Standard dental labs acquires BRLIT Dental Laboratory
Standard Dental Labs has completed its acquisition of BRLIT Dental Laboratory, a Sarasota‑based lab with nearly five decades of history, marking a major milestone in the company's…
Company lists
Life science tools, genomics, oncology, medical devices, nutraceuticals and more: the companies building life sciences in Los Angeles, California, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 391 life sciences companies in Los Angeles, last 24 months: 24 M&A deals · 10 funding rounds · 7 Contracts. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: May 2026.
Standard Dental Labs has completed its acquisition of BRLIT Dental Laboratory, a Sarasota‑based lab with nearly five decades of history, marking a major milestone in the company's…
ANEUVO, a medical device startup developing neuromodulation implants for spinal cord injury, announced a $22 million Series C to accelerate clinical development of its implantable therapy.
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Immix Biopharma, Inc. ... net proceeds to Immix from the offering, after deducting the underwriting discounts, commissions and other offering expenses, were approximately $93.7 million.
Two startups — Pelage Pharmaceuticals and Veradermics — raised a combined $270 million to develop treatments for a common form of hair loss, known clinically as androgenetic alopecia.
Standard Dental Labs Inc. today announced that it has signed a binding agreement on November 4th, 2025 to acquire Dream Dentistry Labs, LLC.
Pelage Pharmaceuticals raised $120 million in Series B funding
The Plug Drink, a Los Angeles-based liver health supplement brand, raised $5 million in equity and debt in venture capital.
MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.
On August 24, 2025, scPharmaceuticals entered into a merger agreement with MannKind Corporation, which will acquire all outstanding shares of scPharmaceuticals through a tender offer.
Generous Brands, the parent company of Bolthouse Farms and Evolution Fresh, has signed a deal to acquire kombucha maker Health-Ade, expanding its presence in the functional beverage market.
Acelyrin, Alumis boards approve merger: The companies fended off a takeover attempt by Kevin Tang's Concentra Biosciences and now expect to complete the deal sometime in the second quarter.
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company ... today announced that its stockholders voted to…
Concentra in late February came in between the planned merger, offering to scoop up Acelyrin for $3 per share, which would total about $300 million, versus its trade price of $2.17 at…
Alumis Inc. (Nasdaq: ALMS) ... and ACELYRIN, INC. (Nasdaq: SLRN) ... have jointly filed a definitive proxy statement/prospectus with the U.S. Securities and Exchange Commission in…
Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update…
Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer…
ACELYRIN, INC. ... determined that the unsolicited indication of interest from Concentra Biosciences, LLC, ... is not reasonably expected to result in a superior proposal to the planned…
"Acelyrin (SLRN) "confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP is the controlling shareholder, to…
Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) (“ Safe Supply ” or the “ Company “) and Safety Strips Tech Corp., a private company (“ SSTC ” or “ Safety Strips “)…
Two weeks ago, Acelyrin announced it had entered into a definitive agreement to merge with fellow immune player Alumis.
In its second private placement this year, Cougar Biotechnology Inc. raised gross proceeds of $87 million to support its cancer clinical trials.
Response Genetics (Los Angeles), a company focused on the development of molecular diagnostic tests for cancer, reported raising $4 million from a private placement of newly issued…
Kite Pharma Inc. priced a public offering of about 3.6 million shares at $69 per share for gross proceeds of about $250.1 million.
In news released today, the Los Angeles-based company merged with public shell SRKP 4 Inc., creating a public entity in which Cougar stockholders hold 100 percent of the equity.
Celera (Rockville, Maryland), a business of Applera (Norwalk, Connecticut), yesterday reported an agreement to purchase cardiovascular healthcare company Berkeley Heart Lab (BHL;…
Celera (Alameda, California) reported completing the acquisition of Berkeley HeartLab (BHL; Burlingame, California) for about $195 million in cash.
Pixium Vision SA reported that its merger with Second Sight Medical Products Inc. has foundered.
Capricor will receive an up-front payment of $20 million. Capricor will handle development and manufacturing duties for deramiocel while Nippon Shinyaku will be responsible for the sales…
Response Genetics Inc., of Los Angeles, said Hitachi Chemical Co. Ltd., of Tokyo, will begin using the company's techniques to extract genetic information from formalin-fixed…
Few life sciences companies in Los Angeles, California publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 286 active companies.

Developer of drugs for immunology
ImmunologyUS$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of antibody-based therapeutics for the treatment of cancer
OncologyUS$412.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of multimodal brain measurement technology for neuromedicine
Wearable technologyUS$158.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developing phage therapeutics to combat antibiotic-resistant bacterial infections
Infectious diseasesUS$154.50m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for hair loss treatment in men and women
DermatologyUS$150.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of human cell interaction platform for drug discovery
GenomicsUS$110.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: High-throughput bioassays, retinal gene‑therapy compounds, cell signaling analytics, pathogen diagnostics
CPC C12N15/85, C12Q1/6853, C12N15/1055Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Human milk-based nutrition for vulnerable infants, improving health outcomes
Nutraceuticals techUS$97.88m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Human milk-derived nutritional and therapeutic products for infant and clinical nutrition
CPC A23C9/206, A23C9/1422, A61K35/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of miniature robots for drug delivery
Drug deliveryUS$63.20m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61B34/73, A61M37/0092, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of tyrosine kinase inhibitor for the treatment of breast cancer
Women healthUS$60.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Immune imaging technology for cancer and autoimmune disease management
Imaging diagnosticsUS$59.64m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting immune cell receptors and tumor-specific antigens
CPC C07K16/2815, C07K16/2809, C07K16/3069Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of cell therapies
Diversified pharmaceuticalsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small-molecule drugs
Drug deliveryFocus: Dry powder inhaler devices and pulmonary drug formulation/composition technologies.
CPC C07D241/08, A61K38/28, A61K9/0075Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI-based solutions for pathological image analysis
Life sciences techUS$48.83m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered digital pathology: virtual staining, immunostain analysis, and analyte detection.
CPC G06T11/00, G06V20/695, G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of synbiotics for simulating gut microbiome
Microbiome therapeuticsFocus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufactures vitamin supplements using encapsulation technology
Nutraceuticals techUS$40.30m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Internet-first brand offering multi-category nutritious products
Nutraceuticals techUS$36.24m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule cancer therapeutics that target DNA replication and integrity
Life sciences platforms and toolsUS$31.22m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Solid-state pharmaceutical forms of deoxycytidine kinase inhibitor drugs
CPC A61P25/00, A61K31/5377, C07D417/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Precision diagnostics for gastrointestinal diseases, leveraging microbiome discoveries for optimal treatment
GastroenterologyUS$23.03m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Precision medicine company improving lives with mTOR-driven disease therapies
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of nutritional supplements for prenatal care
Nutraceuticals techUS$22.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of prebiotic, probiotic, and algal extracts supplements
Nutraceuticals techUS$22.26m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a medical device for the treatment of spinal cord injuries
NeurologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of nutritional beverages
Nutraceuticals techUS$19.50m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Cybersecurity and technology insights for a safer digital experience
Imaging diagnosticsUS$19.35m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drug delivery methods for pharma-based therapeutics
Drug deliveryUS$18.74m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Monoterpene-derived anticancer pharmaceuticals, especially perillyl alcohol derivatives for cancer therapy.
CPC A61K31/495, C07C29/92, A61K45/06Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Cardio-respiratory monitoring device
Cardiac and vascular disordersUS$17.80m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Acoustic cardiac diagnostics and multisensor pulmonary pressure monitoring for cardiovascular health
CPC A61B7/04, A61B5/02028Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of software and services for pharmaceutical state licensing and compliance
Grc softwareUS$12.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics to treat gastrointestinal diseases
GastroenterologyUS$12.56m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of jet lag prevention and recovery kits for travelers. It offers a system combining patented supplements, blue-light blocking glasses, and an AI-driven app to synchronize circadian rhythms with new time zones. The kits are designed to minimize inflammation, boost energy, and improve sleep quality, enabling travelers to arrive feeling refreshed and ready for activities. The app provides customized plans for eating, sleeping, and supplement use, adapting to individual itineraries and preferences. Additional add-ons, such as compression socks and neuromuscular stimulators, further enhanc
Fitness & wellness techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of next-generation pharmaceuticals for neuropsychiatric conditions and substance use disorders
NeurologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of single-cell assays for cell analysis
Life sciences platforms and toolsUS$9.87m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immune-modulating therapies for the treatment of cancer
ImmunotherapyFocus: Cytokine fusion protein therapeutics for immune modulation and targeted biologic therapies
CPC C07K14/54, C07K14/5443, C07K16/2803Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a surgical navigation system using augmented reality technology
Surgical instrumentsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of strategic insights for biopharma commercial diligence
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a portable device for the diagnosis of stroke
NeurologyUS$6.70m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Noninvasive brain monitoring sensors and coil positioning systems for handheld diagnostics.
CPC A61B5/0042, A61B5/245, A61B5/0536Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of plant-based hangover drinks
Nutraceuticals techUS$6.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Voltage regulation and power management circuit design
CPC G01R19/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of nutrition products for children
Nutraceuticals techUS$6.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of the solutions for the detection of antibiotic susceptibility in urinary tract infections
GenomicsUS$6.21m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/689, C12Q1/44, C12Q1/18Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Leading WebOps platform for automating and growing applications, websites, and hosting
OphthalmologyUS$6.14m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an implantable device designed to deliver therapeutic drugs
OncologyUS$5.75m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Building a databank of patient-derived data for advanced research
Data as a serviceFocus: Negative-pressure wound therapy interfaces for ostomy faceplate devices
CPC A61F5/448Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of regulatory information management (RIM) platform for the MedTech industry
Life sciences techFocus: Patents concentrated in computing, sensing & instrumentation
CPC G06F16/84Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Digital social networking platform for healthcare professionals
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of technology that integrates genetic data into software applications
GenomicsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapies for rare genetic diseases
Rare diseasesEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapies for hematopoietic diseases
Gene therapyFocus: Design of enhanced viral vectors for gene therapy and transgene expression
CPC C12N15/86Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of science-focused brand addressing the aging process of hair with a holistic approach
DermatologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Advanced sperm quality testing for informed fertility treatment decisions
Healthcare itEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of a direct-to-consumer, non-clinical genetic tests
Diversified diagnosticsUS$3.75m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders
NeurologyUS$2.92m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Non-invasive neuromodulation devices targeting trigeminal nerve for neuropsychiatric therapy
CPC A61N1/0456, A61N1/36025, A61N1/36146Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Los Angeles on RadarBrowse life sciences companies in Los Angeles, from genomics and oncology to medical devices and life science tools. Discover life science companies working on research, therapeutics and diagnostics.
Research platforms, instruments and tools for life sciences.

Provider of human cell interaction platform for drug discovery
Genomics
AI-based solutions for pathological image analysis
Life sciences tech
Developer of small molecule cancer therapeutics that target DNA replication and integrity
Life sciences platforms and tools
Provider of strategic insights for biopharma commercial diligence
Life sciences tech
Building a databank of patient-derived data for advanced research
Data as a serviceLife sciences companies focused on genomics and genetic analysis.

Developing phage therapeutics to combat antibiotic-resistant bacterial infections
Infectious diseases
Provider of human cell interaction platform for drug discovery
Genomics
Immune imaging technology for cancer and autoimmune disease management
Imaging diagnostics
Developer of synbiotics for simulating gut microbiome
Microbiome therapeutics
Provider of the solutions for the detection of antibiotic susceptibility in urinary tract infections
GenomicsLife sciences companies developing cancer diagnostics and treatments.

Developer of antibody-based therapeutics for the treatment of cancer
Oncology
Developer of tyrosine kinase inhibitor for the treatment of breast cancer
Women health
Immune imaging technology for cancer and autoimmune disease management
Imaging diagnostics
Developer of small molecule cancer therapeutics that target DNA replication and integrity
Life sciences platforms and tools
Developer of immune-modulating therapies for the treatment of cancer
ImmunotherapyDevelopers of medical devices, monitoring systems and diagnostic technology.

Developer of multimodal brain measurement technology for neuromedicine
Wearable technology
Developer of a medical device for the treatment of spinal cord injuries
Neurology
Cardio-respiratory monitoring device
Cardiac and vascular disorders
Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders
Neurology
Provider of a device and app for monitoring babies
Disease self managementLife sciences businesses developing supplements and nutritional products.

Human milk-based nutrition for vulnerable infants, improving health outcomes
Nutraceuticals tech
Provider of nutritional supplements for prenatal care
Nutraceuticals tech
Manufacturer of prebiotic, probiotic, and algal extracts supplements
Nutraceuticals tech
Provider of nutritional beverages
Nutraceuticals tech
Provider of jet lag prevention and recovery kits for travelers. It offers a system combining patented supplements, blue-light blocking glasses, and an AI-driven app to synchronize circadian rhythms with new time zones. The kits are designed to minimize inflammation, boost energy, and improve sleep quality, enabling travelers to arrive feeling refreshed and ready for activities. The app provides customized plans for eating, sleeping, and supplement use, adapting to individual itineraries and preferences. Additional add-ons, such as compression socks and neuromuscular stimulators, further enhanc
Fitness & wellness techRecently founded life sciences companies in Los Angeles.

Provider of software and services for pharmaceutical state licensing and compliance
Grc software
Developer of next-generation pharmaceuticals for neuropsychiatric conditions and substance use disorders
Neurology
Developer of immune-modulating therapies for the treatment of cancer
ImmunotherapyDeveloper of a surgical navigation system using augmented reality technology
Surgical instruments
Provider of strategic insights for biopharma commercial diligence
Life sciences techLife sciences companies in Los Angeles with hiring activity.

Human milk-based nutrition for vulnerable infants, improving health outcomes
Nutraceuticals tech
Developer of tyrosine kinase inhibitor for the treatment of breast cancer
Women health
Developer of small-molecule drugs
Drug delivery
Manufactures vitamin supplements using encapsulation technology
Nutraceuticals tech
Internet-first brand offering multi-category nutritious products
Nutraceuticals techLife sciences companies in Los Angeles that are publicly listed.

Developer of drugs for immunology
Immunology
Developer of tyrosine kinase inhibitor for the treatment of breast cancer
Women health
Developer of small-molecule drugs
Drug delivery
Precision medicine company improving lives with mTOR-driven disease therapies
Oncology
Developer of drug delivery methods for pharma-based therapeutics
Drug deliveryThe most-installed Android apps published by life sciences companies headquartered in Los Angeles — 903K installs between them. 5 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Los Angeles compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 391 life sciences companies in Los Angeles among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of Los Angeles Life Sciences Industry Landscape of the United States AdTech Industry Landscape of Los AngelesThe financials above are one chapter. The full life sciences landscape of Los Angeles maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
79 life sciences companies in Los Angeles have recorded equity funding, US$2.49bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
ImmunologyDeveloper of drugs for immunology
OncologyDeveloper of antibody-based therapeutics for the treatment of cancer
Wearable technologyDeveloper of multimodal brain measurement technology for neuromedicine
Infectious diseasesDeveloping phage therapeutics to combat antibiotic-resistant bacterial infections
DermatologyDeveloper of therapeutics for hair loss treatment in men and women
GenomicsProvider of human cell interaction platform for drug discovery
Nutraceuticals techHuman milk-based nutrition for vulnerable infants, improving health outcomes
Drug deliveryDeveloper of miniature robots for drug delivery
Women healthDeveloper of tyrosine kinase inhibitor for the treatment of breast cancer
Imaging diagnosticsImmune imaging technology for cancer and autoimmune disease management
Diversified pharmaceuticalsDeveloper of cell therapies
Drug deliveryDeveloper of small-molecule drugs
Founders
Details not available
Life sciences techAI-based solutions for pathological image analysis
Microbiome therapeuticsDeveloper of synbiotics for simulating gut microbiome
Nutraceuticals techManufactures vitamin supplements using encapsulation technology
Founders
Details not available
Nutraceuticals techInternet-first brand offering multi-category nutritious products
US$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$412.30m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$158.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$154.50m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$150.80m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$110.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: High-throughput bioassays, retinal gene‑therapy compounds, cell signaling analytics, pathogen diagnostics
CPC C12N15/85, C12Q1/6853, C12N15/1055Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$97.88m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Human milk-derived nutritional and therapeutic products for infant and clinical nutrition
CPC A23C9/206, A23C9/1422, A61K35/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$63.20m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61B34/73, A61M37/0092, A61B34/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$60.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$59.64m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting immune cell receptors and tumor-specific antigens
CPC C07K16/2815, C07K16/2809, C07K16/3069Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Dry powder inhaler devices and pulmonary drug formulation/composition technologies.
CPC C07D241/08, A61K38/28, A61K9/0075Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.83m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered digital pathology: virtual staining, immunostain analysis, and analyte detection.
CPC G06T11/00, G06V20/695, G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$40.30m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.24m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in Los Angeles. 186 of 286 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
DermatologyProvider of science-focused brand addressing the aging process of hair with a holistic approach
Founders
Details not available
Herbalife is a nutrition company that offers dietary supplements and products for individuals and distributors.
Founders
Details not available
Life sciences platforms and toolsResponse Genetics is an innovative and rapidly growing life sciences company engaged in the research and development.
Founders
Details not available
Life sciences techAI-based solutions for pathological image analysis
Life sciences techConnecting patients with clinical trials, prioritizing patient voices for equitable research
Life sciences techProvider of regulatory information management (RIM) platform for the MedTech industry
Grc softwareProvider of software and services for pharmaceutical state licensing and compliance
OncologyProvider of an implantable device designed to deliver therapeutic drugs
GenomicsProvider of products & services for DNA and RNA Next Generation Sequencing sample preparation
Life sciences techDevelops a software suite for the modeling and design of novel protein binders
Founders
Details not available
ImmunologyDeveloper of drugs for immunology
Life sciences techProvider of machine learning data-analysis platform for life-science researchers
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A23L2/52, A61K31/522Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Molecular diagnostic kits and assays for detecting oncogenic mutations and biomarker expression
CPC C12Q1/6886, C12N9/1088, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.83m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered digital pathology: virtual staining, immunostain analysis, and analyte detection.
CPC G06T11/00, G06V20/695, G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G06F16/84Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$5.75m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.89m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Los Angeles with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Microbiome therapeuticsDeveloper of synbiotics for simulating gut microbiome
ImmunologyDeveloper of drugs for immunology
Data as a serviceBuilding a databank of patient-derived data for advanced research
Nutraceuticals techProvider of nutritional supplements for prenatal care
Life sciences techDigital social networking platform for healthcare professionals
Nutraceuticals techOnline platform offering vitamins for women's health
GastroenterologyPrecision diagnostics for gastrointestinal diseases, leveraging microbiome discoveries for optimal treatment
Imaging diagnosticsImmune imaging technology for cancer and autoimmune disease management
Gene therapyDeveloper of gene therapies for hematopoietic diseases
Disease self managementProvider of a device and app for monitoring babies
GenomicsManufacturer of devices for muscular dystrophy treatment
ImmunologyDeveloper of therapies for the treatment of autoinflammatory diseases
Focus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Negative-pressure wound therapy interfaces for ostomy faceplate devices
CPC A61F5/448Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$22.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$23.03m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$59.64m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting immune cell receptors and tumor-specific antigens
CPC C07K16/2815, C07K16/2809, C07K16/3069Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design of enhanced viral vectors for gene therapy and transgene expression
CPC C12N15/86Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$520k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in Los Angeles founded in the last four years, newest first.
ImmunologyDeveloper of oral small-molecule therapeutics for immunology targets traditionally treated by biologics
Founders
Details not available
Nutraceuticals techDeveloper of NAD+ enhancement solutions and research
Nutraceuticals techRetailer of dietary supplements formulated to support cognitive function
Founders
Details not available
Company developing targeted gene delivery solutions
Grc softwareProvider of software and services for pharmaceutical state licensing and compliance
Rare diseasesDeveloper of gene therapies for rare genetic diseases
Life sciences techProvider of strategic insights for biopharma commercial diligence
Founders
Details not available
Life sciences platforms and toolsDeveloper of qPCR-based microbiome profiling assays and services
Life sciences platforms and toolsDeveloper of 3D multicellular organoid systems
Nutraceuticals techDeveloper of hypoallergenic novel food products
Life sciences platforms and toolsProvider of cryo-EM and AI drug design services
Infectious diseasesDeveloper of a point-of-care in-vitro diagnostic for device for infectious diseases
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Drug deliveryDeveloper of small-molecule drugs
Founders
Details not available
Women healthDeveloper of tyrosine kinase inhibitor for the treatment of breast cancer
Cardiac and vascular disordersDeveloper of regenerative medicine for cardiovascular disorders
NanotechnologyDeveloper of therapeutics for amyloidosis, autoimmune diseases, and oncology indications
Infectious diseasesDeveloper of phage therapeutics
OncologyPrecision medicine company improving lives with mTOR-driven disease therapies
OncologyDeveloper of T-cell therapies against cancer and drug resistance
Founders
Details not available
ImmunologyDeveloper of drugs for immunology
Life sciences techAI-based solutions for pathological image analysis
Life sciences techProvider of AI powered data solutions for life sciences
NeurologyBioelectronic devices and therapies for regenerative medicine
Life sciences platforms and toolsResponse Genetics is an innovative and rapidly growing life sciences company engaged in the research and development.
Founders
Details not available
Focus: Dry powder inhaler devices and pulmonary drug formulation/composition technologies.
CPC C07D241/08, A61K38/28, A61K9/0075Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$60.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Targeted nanoparticle delivery of therapeutics for cancer and inflammatory diseases
CPC A61K47/6909, A61K9/1075, A61K31/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$550.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic antibodies targeting inflammatory pathways for autoimmune skin and joint diseases
CPC A61K39/39591, C07K16/244, A61P17/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.83m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered digital pathology: virtual staining, immunostain analysis, and analyte detection.
CPC G06T11/00, G06V20/695, G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Molecular diagnostic kits and assays for detecting oncogenic mutations and biomarker expression
CPC C12Q1/6886, C12N9/1088, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in Los Angeles. Open a company to see what it sells, who runs it and how far it has come.
50 life sciences companies in Los Angeles work in nutraceuticals tech. Shown: the best-documented.
Nutraceuticals techHuman milk-based nutrition for vulnerable infants, improving health outcomes
Microbiome therapeuticsDeveloper of synbiotics for simulating gut microbiome
Nutraceuticals techManufactures vitamin supplements using encapsulation technology
Founders
Details not available
Nutraceuticals techManufacturer of prebiotic, probiotic, and algal extracts supplements
Nutraceuticals techProvider of nutritional supplements for prenatal care
Developer of plant-based hangover drinks
Founders
Details not available
Nutraceuticals techProvider of nutritional beverages
Nutraceuticals techInternet-first brand offering multi-category nutritious products
Nutraceuticals techOnline platform offering vitamins for women's health
Nutraceuticals techProvider of nutrition products for children
Nutraceuticals techProvider of functional mushroom ingredients for mental health
Founders
Details not available
Nutraceuticals techAll-natural nutraceutical products for healthier, longer, pain-free living
US$97.88m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Human milk-derived nutritional and therapeutic products for infant and clinical nutrition
CPC A23C9/206, A23C9/1422, A61K35/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$40.30m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$22.26m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$22.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Voltage regulation and power management circuit design
CPC G01R19/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$19.50m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$36.24m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.50m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$601k across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
38 life sciences companies in Los Angeles work in life sciences platforms and tools. Shown: the best-documented.
Diversified diagnosticsProvider of a direct-to-consumer, non-clinical genetic tests
GenomicsProvider of products & services for DNA and RNA Next Generation Sequencing sample preparation
Life sciences platforms and toolsIn vitro diagnostics solutions advancing laboratory medicine and improving healthcare
Founders
Details not available
Life sciences platforms and toolsDeveloper of automated single-cell contractility screening system for drug discovery
Life sciences platforms and toolsDeveloper of single-cell assays for cell analysis
Founders
Details not available
Life sciences platforms and toolsAI-enabled smart measurement systems using computational microscopy technology for micro-object characterization
Life sciences platforms and toolsProvider of bioanalytical services for molecular analysis
Life sciences platforms and toolsDeveloper of small molecule cancer therapeutics that target DNA replication and integrity
Life sciences platforms and toolsDeveloper of locally deliverable cell therapies
Founders
Details not available
Life sciences platforms and toolsResponse Genetics is an innovative and rapidly growing life sciences company engaged in the research and development.
Founders
Details not available
Entos drives chemical and biological innovation through thousand-fold speed ups in molecular prediction with transformative improvements in accuracy.
Founders
Details not available
Life sciences techProvider and developer of molecular instruments for drug development
Founders
Details not available
US$3.75m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.89m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.12m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$9.87m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$2.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$31.22m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: Solid-state pharmaceutical forms of deoxycytidine kinase inhibitor drugs
CPC A61P25/00, A61K31/5377, C07D417/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Molecular diagnostic kits and assays for detecting oncogenic mutations and biomarker expression
CPC C12Q1/6886, C12N9/1088, C12Q1/6806Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Predicting molecular properties via atomic-orbital-based computational chemistry models
CPC G16C10/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
34 life sciences companies in Los Angeles work in genomics. Shown: the best-documented.
Microbiome therapeuticsDeveloper of synbiotics for simulating gut microbiome
GenomicsProvider of human cell interaction platform for drug discovery
Infectious diseasesDeveloping phage therapeutics to combat antibiotic-resistant bacterial infections
Diversified diagnosticsProvider of a direct-to-consumer, non-clinical genetic tests
GenomicsDeveloper of technology that integrates genetic data into software applications
Fitness & wellness techProvider of jet lag prevention and recovery kits for travelers. It offers a system combining patented supplements, blue-light blocking glasses, and an AI-driven app to synchronize circadian rhythms with new time zones. The kits are designed to minimize inflammation, boost energy, and improve sleep quality, enabling travelers to arrive feeling refreshed and ready for activities. The app provides customized plans for eating, sleeping, and supplement use, adapting to individual itineraries and preferences. Additional add-ons, such as compression socks and neuromuscular stimulators, further enhanc
GenomicsProvider of products & services for DNA and RNA Next Generation Sequencing sample preparation
Life sciences platforms and toolsIn vitro diagnostics solutions advancing laboratory medicine and improving healthcare
Founders
Details not available
Healthcare itTailored cancer therapy selection through deep molecular profiling for each patient
GenomicsManufacturer of devices for muscular dystrophy treatment
GenomicsProvider of the solutions for the detection of antibiotic susceptibility in urinary tract infections
Healthcare itAdvanced sperm quality testing for informed fertility treatment decisions
Focus: Genetically engineered herbicide‑resistant sorghum and alfalfa via ACC gene mutations
CPC A01H5/12, C12N15/8274, A01H5/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$110.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: High-throughput bioassays, retinal gene‑therapy compounds, cell signaling analytics, pathogen diagnostics
CPC C12N15/85, C12Q1/6853, C12N15/1055Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$154.50m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$3.75m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.89m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$6.21m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/689, C12Q1/44, C12Q1/18Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
34 life sciences companies in Los Angeles work in life sciences tech. Shown: the best-documented.
Data as a serviceBuilding a databank of patient-derived data for advanced research
GenomicsProvider of human cell interaction platform for drug discovery
Life sciences techDigital social networking platform for healthcare professionals
Life sciences techAI-based solutions for pathological image analysis
GenomicsDeveloper of technology that integrates genetic data into software applications
Life sciences techProvider of regulatory information management (RIM) platform for the MedTech industry
Grc softwareProvider of software and services for pharmaceutical state licensing and compliance
Healthcare itTailored cancer therapy selection through deep molecular profiling for each patient
Life sciences techAI-enabled clinical data management platform for biotech companies
Life sciences techProvider of a digital platform to develop and discover drugs
Life sciences techProvider of strategic insights for biopharma commercial diligence
Founders
Details not available
Life sciences techProvider of AI powered data solutions for life sciences
Focus: Negative-pressure wound therapy interfaces for ostomy faceplate devices
CPC A61F5/448Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$110.00m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: High-throughput bioassays, retinal gene‑therapy compounds, cell signaling analytics, pathogen diagnostics
CPC C12N15/85, C12Q1/6853, C12N15/1055Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.83m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered digital pathology: virtual staining, immunostain analysis, and analyte detection.
CPC G06T11/00, G06V20/695, G01N33/54366Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G06F16/84Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
183 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.